• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

转移性肾细胞癌的手术治疗方法：文献综述

Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review.

作者信息

Matuszczak Milena, Kiljańczyk Adam, Salagierski Maciej

机构信息

Department of Urology, Collegium Medicum, University of Zielona Góra, 65-046 Zielona Góra, Poland.

出版信息

Cancers (Basel). 2023 Mar 16;15(6):1804. doi: 10.3390/cancers15061804.

DOI:10.3390/cancers15061804
PMID:36980688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10046362/
Abstract

The treatment of metastatic renal cell carcinoma has undergone considerable advances in the last two decades. Cytoreductive nephrectomy and metastasectomy retains a role in patients with a limited metastatic burden. The choice of optimal treatment regimen remains a matter of debate. The article summarises the current role of surgery in metastatic kidney cancer.

摘要

在过去二十年中，转移性肾细胞癌的治疗取得了显著进展。减瘤性肾切除术和转移灶切除术在转移负担有限的患者中仍发挥着作用。最佳治疗方案的选择仍是一个有争议的问题。本文总结了手术在转移性肾癌中的当前作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf2/10046362/9915f67b45c8/cancers-15-01804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf2/10046362/1a63d015b05c/cancers-15-01804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf2/10046362/9915f67b45c8/cancers-15-01804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf2/10046362/1a63d015b05c/cancers-15-01804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf2/10046362/9915f67b45c8/cancers-15-01804-g002.jpg

相似文献

1
Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review.转移性肾细胞癌的手术治疗方法：文献综述
Cancers (Basel). 2023 Mar 16;15(6):1804. doi: 10.3390/cancers15061804.
2
[Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].[手术（减瘤性肾切除术和转移灶切除术）在转移性肾细胞癌治疗中的作用：文献综述]
Prog Urol. 2010 Dec;20(13):1175-83. doi: 10.1016/j.purol.2010.06.001. Epub 2010 Jul 6.
3
Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.免疫治疗基础治疗后行细胞减积性肾切除术治疗转移性肾细胞癌：病例系列及文献复习。
Curr Oncol. 2021 May 20;28(3):1921-1926. doi: 10.3390/curroncol28030178.
4
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.去分化肾细胞癌的作用：肉瘤样肾细胞癌病例系列及文献复习
Curr Oncol. 2022 Aug 3;29(8):5475-5488. doi: 10.3390/curroncol29080433.
5
Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer.转移性肾癌的减瘤性肾切除术及肾切除术/完整转移灶切除术
ScientificWorldJournal. 2007 Feb 19;7:768-78. doi: 10.1100/tsw.2007.145.
6
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.手术在晚期肾细胞癌中的作用：细胞减灭性肾切除术和转移灶切除术。
Hematol Oncol Clin North Am. 2011 Aug;25(4):753-64. doi: 10.1016/j.hoc.2011.05.002.
7
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.系统评价细胞减积性肾切除术在靶向治疗时代及以后的作用：转移性肾细胞癌的个体化治疗方法。
Eur Urol. 2019 Jan;75(1):111-128. doi: 10.1016/j.eururo.2018.09.016. Epub 2018 Oct 25.
8
Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy.
Nat Clin Pract Urol. 2004 Nov;1(1):26-30. doi: 10.1038/ncpuro0029.
9
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.晚期和转移性肾细胞癌的外科治疗：多学科方法
Front Oncol. 2017 May 31;7:107. doi: 10.3389/fonc.2017.00107. eCollection 2017.
10
Cytoreductive nephrectomy in metastatic renal cell carcinoma.转移性肾细胞癌的减瘤性肾切除术
Curr Opin Urol. 2008 Sep;18(5):474-80. doi: 10.1097/MOU.0b013e32830a4f21.

引用本文的文献

1
Acute kidney injury: pathogenesis and therapeutic interventions.急性肾损伤：发病机制与治疗干预
Mol Biomed. 2025 Sep 5;6(1):61. doi: 10.1186/s43556-025-00293-4.
2
Gastric metastasis subsequent to renal cell carcinoma surgery: a case report.肾细胞癌手术后发生胃转移：一例报告
Front Oncol. 2025 Aug 18;15:1624528. doi: 10.3389/fonc.2025.1624528. eCollection 2025.
3
Next-generation sequencing identifies the mutational signature of double primary and metastatic malignancies: A case report.下一代测序鉴定双原发性和转移性恶性肿瘤的突变特征：一例报告。

本文引用的文献

1
The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy.聚焦治疗和主动监测在小肾肿瘤治疗中的作用
Biomedicines. 2022 Oct 14;10(10):2583. doi: 10.3390/biomedicines10102583.
2
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南：2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
3
Cancer statistics, 2022.癌症统计数据，2022 年。
Curr Urol. 2025 Sep;19(5):359-362. doi: 10.1097/CU9.0000000000000251. Epub 2024 Jun 10.
4
Metabolomic Understanding of variable risk factors for kidney cancer: a two-sample Mendelian randomization study.肾癌可变风险因素的代谢组学理解：一项两样本孟德尔随机化研究
Discov Oncol. 2025 Jul 28;16(1):1429. doi: 10.1007/s12672-025-03151-5.
5
Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer.TCS9725对TNKS1和CDK8的选择性双重抑制减弱了肾癌中的STAT1/β-连环蛋白/TGFβ1信号传导。
Curr Issues Mol Biol. 2025 Jun 17;47(6):463. doi: 10.3390/cimb47060463.
6
Resolution of Refractory Hypertension Following Radical Nephrectomy for Renal Cell Carcinoma: A Case Report from Somalia in Resource Limit Setting.肾细胞癌根治性肾切除术后难治性高血压的缓解：来自资源有限地区索马里的一例报告
Cancer Manag Res. 2025 Jul 12;17:1369-1375. doi: 10.2147/CMAR.S530092. eCollection 2025.
7
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.立体定向体部放射治疗用于颅外寡转移肾细胞癌：现状与未来展望
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251357344. doi: 10.1177/15330338251357344. Epub 2025 Jul 17.
8
Establishing cM0 (i+) stage criteria in localized renal cell carcinoma based on postoperative circulating tumor cells monitoring.基于术后循环肿瘤细胞监测建立局限性肾细胞癌的cM0（i+）期标准。
BMC Cancer. 2025 Mar 11;25(1):436. doi: 10.1186/s12885-025-13815-8.
9
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy.肾细胞癌转移的分子机制及潜在治疗靶点
Front Cell Dev Biol. 2025 Jan 20;13:1521151. doi: 10.3389/fcell.2025.1521151. eCollection 2025.
10
Integrative Analysis of Radiation-Induced Senescence-Associated Secretory Phenotype Factors in Kidney Cancer Progression.肾癌进展中辐射诱导的衰老相关分泌表型因子的综合分析
Genes (Basel). 2025 Jan 15;16(1):85. doi: 10.3390/genes16010085.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.《肾癌临床实践指南》第 3 版 2022 年版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Jan;20(1):71-90. doi: 10.6004/jnccn.2022.0001.
5
Surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus.肾细胞癌伴下腔静脉瘤栓的外科治疗。
Surg Today. 2022 Aug;52(8):1125-1133. doi: 10.1007/s00595-021-02429-9. Epub 2022 Jan 3.
6
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.肾脏肿块和局限性肾细胞癌：评估、管理和随访：AUA 指南：第 1 部分。
J Urol. 2021 Aug;206(2):199-208. doi: 10.1097/JU.0000000000001911. Epub 2021 Jul 11.
7
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.肾肿物与局限性肾癌：评估、管理及随访：美国泌尿外科学会指南：第二部分
J Urol. 2021 Aug;206(2):209-218. doi: 10.1097/JU.0000000000001912. Epub 2021 Jul 11.
8
Pulmonary metastasectomy in renal cell carcinoma: a mainstay of multidisciplinary treatment.肾细胞癌的肺转移瘤切除术：多学科治疗的主要手段
J Thorac Dis. 2021 Apr;13(4):2636-2642. doi: 10.21037/jtd-2019-pm-10.
9
The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.转移性肾细胞癌转移灶切除术对总生存的影响：系统评价和荟萃分析。
Urol Oncol. 2021 Jul;39(7):422-430. doi: 10.1016/j.urolonc.2021.02.026. Epub 2021 Apr 29.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.